MLH1 and colonic neoplasm: LS is associated with an increased predisposition to different cancer types, primarily colon cancer (occurring in 46–61% of individuals with a pathogenic MLH1 variant) or endometrial cancer (occurring in 34–54% of individuals with a pathogenic MLH1 variant) (2, 21).